Full Text
The German Quota System as a Model for Biosimilar Cost Savings in Epoetin Treatment

Abstract

Authors

K. Walsh D. Berger W. Bodenmueller J. Whitehouse

Back to Volume 16, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×